GoKawiilThank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
Anticancer antibodies can evolve to cause autoimmune brain disease
Why This Matters
This research highlights the potential risks associated with anticancer antibody therapies, which can inadvertently trigger autoimmune brain diseases. Understanding these side effects is crucial for developing safer treatments and improving patient outcomes in the biotech industry. For consumers, it underscores the importance of monitoring and managing potential adverse effects of advanced immunotherapies.
Key Takeaways
- Anticancer antibodies can evolve to cause autoimmune brain conditions.
- Safety monitoring is essential for immunotherapy treatments.
- This research informs the development of safer, more targeted therapies.
Explore topics:
anticancer antibodies
autoimmune brain disease
nature.com
browser support
internet explorer
Get alerts for these topics